Copley Acquisition Corp (COPL) is a Finance company listed on NYSE. In the last 30 days Quantisnow tracked 7 wire items for COPL, including 4 SEC filings, 2 13D/G filings and 1 offering. The most recent was published Nov 12, 2026.
News · 26 weeks17+133%
2026-05-172026-11-08
Mix1290d
- SEC Filings8(67%)
- 13D/G2(17%)
- Other1(8%)
- Offering1(8%)
Activity · 52 weeks2117 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- 13D/GAmendment: SEC Form SCHEDULE 13G/A filed by Copley Acquisition CorpSCHEDULE 13G/A - Copley Acquisition Corp (0002045473) (Subject)
- 13D/GAmendment: SEC Form SCHEDULE 13G/A filed by Copley Acquisition CorpSCHEDULE 13G/A - Copley Acquisition Corp (0002045473) (Subject)
- SECCopley Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - Copley Acquisition Corp (0002045473) (Filer)
- PRCopley Acquisition Corp Announces Shareholder Approval of Extension of Termination Date and Contribution to Trust Account to Extend Termination DateHONG KONG, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE:COPL, the "Company")), a special purpose acquisition company, announced today that at an extraordinary general meeting of its shareholders convened on October 29, 2026 and adjourned to November 2, 2026 (the "Extraordinary General Meeting"), the Company’s shareholders approved, by special resolution, a proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association (the "Articles") to permit the Company, by resolution of the Company’s board of directors, to extend the date by which the Company must consummate an initial business combination (the "Termination Date") up to 12 times, by one m
- SECSEC Form DEFA14A filed by Copley Acquisition CorpDEFA14A - Copley Acquisition Corp (0002045473) (Filer)
- SECCopley Acquisition Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form DEF 14A filed by Copley Acquisition CorpDEF 14A - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form 8-K filed by Copley Acquisition Corp8-K - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form 8-K filed by Copley Acquisition Corp8-K - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form PRE 14A filed by Copley Acquisition CorpPRE 14A - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form 10-Q filed by Copley Acquisition Corp10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form NT 10-Q filed by Copley Acquisition CorpNT 10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form SCHEDULE 13G filed by Copley Acquisition CorpSCHEDULE 13G - Copley Acquisition Corp (0002045473) (Subject)
- SECSEC Form SCHEDULE 13G filed by Copley Acquisition CorpSCHEDULE 13G - Copley Acquisition Corp (0002045473) (Subject)
- SECCopley Acquisition Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Copley Acquisition Corp (0002045473) (Filer)
- PRCopley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision OncologyIgnite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology. HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE:COPL) ("Copley"), a special purpose acquisition company and Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"), a leader in pathway-level protein analytics to guide precision oncology, announced today that they have entered into a definitive business combination agreement ("BCA"). Upon the closing of the Combination, Copley and Ignite Proteomics will become wholly owned subsidiaries of a newly formed public holding company, which we intend to name Ignite Proteomics Holdings, Inc. ("PubCo"), and
- SECSEC Form 10-Q filed by Copley Acquisition Corp10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form NT 10-Q filed by Copley Acquisition CorpNT 10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Copley Acquisition CorpSCHEDULE 13G/A - Copley Acquisition Corp (0002045473) (Subject)
- SECSEC Form 10-K filed by Copley Acquisition Corp10-K - Copley Acquisition Corp (0002045473) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Copley Acquisition CorpSCHEDULE 13G/A - Copley Acquisition Corp (0002045473) (Subject)
- SECSEC Form SCHEDULE 13G filed by Copley Acquisition CorpSCHEDULE 13G - Copley Acquisition Corp (0002045473) (Subject)
- SECSEC Form 10-Q filed by Copley Acquisition Corp10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form 10-Q filed by Copley Acquisition Corp10-Q - Copley Acquisition Corp (0002045473) (Filer)
- SECSEC Form SCHEDULE 13G filed by Copley Acquisition CorpSCHEDULE 13G - Copley Acquisition Corp (0002045473) (Subject)
COPL FAQ
5 questionsWhat is the latest news on COPL?
In the last 30 days Quantisnow tracked 7 wire items for COPL: 4 SEC filings, 2 13D/G filings and 1 offering. The most recent was published on November 12, 2026.Where does COPL stock trade?
Copley Acquisition Corp (COPL) is listed on NYSE.What sector and industry is COPL in?
Copley Acquisition Corp operates in the Finance sector.When did Copley Acquisition Corp go public?
Copley Acquisition Corp (COPL) completed its IPO in 2025.How can I track COPL on Quantisnow?
Quantisnow aggregates Copley Acquisition Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COPL to receive live email and push alerts on every new disclosure.